MELISSA LOFTIS: Open Payments
NPI 1619959814 · WARR ACRES, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,951 in 93 payments from 21 companies in 2025. Trend: 2023 $1,960 · 2024 $1,483 · 2025 $1,951
Food & beverage: $1,861Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $307 |
| Astellas Pharma US Inc | 10 | $284 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $256 |
| Novo Nordisk Inc | 14 | $208 |
| PFIZER INC. | 9 | $168 |
| Lilly USA, LLC | 7 | $163 |
| ABBVIE INC. | 5 | $114 |
| Corcept Therapeutics | 3 | $70 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Exact Sciences Corporation | 2 | $40 |
Products named: Kerendia, Veozah, FARXIGA, AIRSUPRA, NURTEC ODT, Ozempic, MOUNJARO, Wegovy.
Industry payments across OK — which companies pay providers there.
